This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Consortia
Rights and permissions
About this article
Cite this article
Ruutu, T., Hermans, J., van Biezen, A. et al. How should corticosteroids be used in the treatment of acute GVHD. Bone Marrow Transplant 22, 614–615 (1998). https://doi.org/10.1038/sj.bmt.1701377
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1701377
This article is cited by
-
Graft-versus-host disease (GvHD) of the tongue and of the oral cavity: a large retrospective study
International Journal of Hematology (2018)
-
Treatment of steroid-resistant acute GVHD with OKT3 and high-dose steroids results in better disease control and lower incidence of infectious complications when compared to high-dose steroids alone: a randomized multicenter trial by the EBMT Chronic Leukemia Working Party
Leukemia (2007)
-
Steroid myopathy in patients with acute graft-versus-host disease treated with high-dose steroid therapy
Bone Marrow Transplantation (2006)
-
OKT3 muromonab as second-line and subsequent treatment in recipients of stem cell allografts with steroid-resistant acute graft-versus-host disease
Bone Marrow Transplantation (2005)